Objective To evaluate the effectiveness and safety of medical sodium hyaluronate gels on the prevention of postoperative adhesion after abdominal and pelvic operation in the Department of general surgery, and discuss its clinical practical value. Methods Total 521 patients undergoing pelvic and abdominal operation were selected and randomly divided into experimental group(263cases)and control group(258cases).The sodium hyaluronate gels were used in the experimental group to coat over the operative area and adjacent parts, but not in the control group. After the surgery, the recorded data was analyzed statisticaly. Results In the experimental group: the mean time for passage of stools(19.8±1.7)h, the leucocyte count increased:8.0%(21cases),physical examination with the pain and discomfort:6.8%(18cases),post-operative adhesion:16cases included 3 cases of type Ⅰ and 13 cases of type Ⅱ.In the control group: the mean time for passage of stools(37.1±3.6)h, the leucocyte count increase:40.7%(105cases),physical examination with the pain and discomfort:24.0%(62cases),post-operative adhesion:94 cases include 39 cases of type Ⅰ and 55 cases of type Ⅱ.Conclusion The sodium hyaluronate gels may decrease the risk of postoperative adhesion formation, reduce the incidence of postoperative infection, pain, discomfort and other symptoms. It is worthy of clinical application and promotion.
Reference from Chinese Journal of General Practice
Writer: Gu Qiu-zhong, the First people's Hospital of Pinghu, Zhejiang, China.
-
singclean | 2017-08-14Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand MasterclassBangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial.
-
singclean | 2017-08-14Singclean to Showcase Innovative Medical Solutions at Key International Exhibitions in Bangkok and Copenhagen
-
singclean | 2017-08-14Singclean Medical Shines at WHX Kuala Lumpur 2025, IVD Solutions Garner Strong Attention Across ASEANKuala Lumpur, Malaysia | July 18, 2025 — From July 16 to 18, WHX Kuala Lumpur 2025, one of ASEAN’s most influential exhibitions for medical devices and laboratory equipment, took place in the Malaysian capital. The event gathered global healthcare technology leaders, and Singclean Medical, a leading Chinese in-vitro diagnostics (IVD) company, made a strong impression with its innovative and reliable total IVD solutions. Backed by solid product performance and technological excellence, Singclean attracted wide interest and recognition from professional attendees.